FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, namely to stimulation of erythropoietin production in bone marrow cells in vitro. Method involves culturing a fraction of bone marrow myelocarocytes in CO2-incubator at 37 °C, 5 % CO2 and 100 % air humidity for 24 hours in a complete culture medium of the following composition: 90 % of RPMI-1640 medium, 10 % ETS, 280 mg/l of L-glutamine, 50 mg/l of gentamycin with addition of JNK inhibitor in effective concentration.
EFFECT: invention enables higher erythropoietin production.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STIMULATION OF GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTION BY BONE MARROW CELLS IN VITRO | 2020 |
|
RU2741784C1 |
METHOD FOR STIMULATING GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION BY BONE MARROW CELLS IN VITRO | 2017 |
|
RU2665818C1 |
METHOD FOR STIMULATING PRODUCTION OF GRANULOCYTE COLONY-STIMULATING FACTOR BY BONE MARROW CELLS IN VITRO | 2021 |
|
RU2770784C1 |
METHOD FOR STIMULATING PRODUCTION OF ERYTHROPOETIN BY BONE MARROW CELLS IN VITRO | 2016 |
|
RU2628882C1 |
METHOD FOR STIMULATING PRODUCTION OF ERYTHROPOIETIN IN A CELL CULTURE in vitro | 2015 |
|
RU2589288C1 |
METHOD OF STIMULATION IN VITRO PLURIPOTENT HEMOPOETIC STEM CELLS | 2010 |
|
RU2439147C1 |
AGENT STIMULATING MESENCHYMAL PROGENITOR CELL FUNCTIONS IN VITRO | 2018 |
|
RU2686718C1 |
METHOD OF STIMULATING PRODUCTION OF GRANULOCYTE COLONY STIMULATING FACTOR BY BONE MARROW CELLS IN VITRO | 2013 |
|
RU2527888C1 |
METHOD FOR DETERMINATION OF PRODUCTION OF STEM CELL HOMING FACTORS | 2009 |
|
RU2399664C1 |
HEMOSTIMULATING MEDICATION | 2012 |
|
RU2505308C1 |
Authors
Dates
2020-02-03—Published
2019-02-19—Filed